Found: 16
Select item for more details and to access through your institution.
Diabetes Therapy Podcast: Real-World Data for Glucose Sensing Technologies in Type 1 Diabetes.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 1, doi. 10.1007/s13300-022-01331-y
- By:
- Publication type:
- Article
Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 11, doi. 10.1007/s13300-022-01340-x
- By:
- Publication type:
- Article
Addendum 1: Forum for Injection Technique and Therapy Expert Recommendations, India.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 29, doi. 10.1007/s13300-022-01332-x
- By:
- Publication type:
- Article
Treatment of the New Era: Long-Term Ticagrelor Monotherapy for the Treatment of Patients with Type 2 Diabetes Mellitus following Percutaneous Coronary Intervention: A Meta-analysis.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 47, doi. 10.1007/s13300-022-01350-9
- By:
- Publication type:
- Article
Spatial Patterns and Determinants of Diabetes Mellitus in Indian Adult Population: a Secondary Data Analysis from Nationally Representative Surveys.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 63, doi. 10.1007/s13300-022-01329-6
- By:
- Publication type:
- Article
Effectiveness, Safety, and Appropriateness in the Use of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide in Type 2 Diabetes: The ENSURE Retrospective Real-World Study.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 77, doi. 10.1007/s13300-022-01328-7
- By:
- Publication type:
- Article
Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 93, doi. 10.1007/s13300-022-01336-7
- By:
- Publication type:
- Article
Therapeutic Effects of Switching to Anagliptin from Other DPP-4 Inhibitors in T2DM Patients with Inadequate Glycemic Control: A Non-interventional, Single-Arm, Open-Label, Multicenter Observational Study.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 109, doi. 10.1007/s13300-022-01339-4
- By:
- Publication type:
- Article
An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 123, doi. 10.1007/s13300-022-01344-7
- By:
- Publication type:
- Article
Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Hypertensive and/or Diabetic People Aged over 60 Years: A Prospective Open-Label Study.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 139, doi. 10.1007/s13300-022-01343-8
- By:
- Publication type:
- Article
Sustained Improvement in Glycemic Control in Emerging Adults with Type 1 Diabetes 2 Years After the Start of the COVID-19 Pandemic.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 153, doi. 10.1007/s13300-022-01346-5
- By:
- Publication type:
- Article
Risk Factors for Glycemic Control in Hospitalized Patients with Type 2 Diabetes Receiving Continuous Subcutaneous Insulin Infusion Therapy.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 167, doi. 10.1007/s13300-022-01342-9
- By:
- Publication type:
- Article
Why Do So Many People with Type 2 Diabetes Who Take Insulin Have Lipohypertrophy? Fate or Educational Deficiencies?
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 179, doi. 10.1007/s13300-022-01341-w
- By:
- Publication type:
- Article
COVID-19 Vaccination and Diabetes Mellitus: How Much Has It Made a Difference to Outcomes Following Confirmed COVID-19 Infection?
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 193, doi. 10.1007/s13300-022-01338-5
- By:
- Publication type:
- Article
Single-Field Fundus Photography for Screening of Diabetic Retinopathy: The Prevalence and Associated Factors in a Population-Based Study.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 205, doi. 10.1007/s13300-022-01348-3
- By:
- Publication type:
- Article
Use of iGlarLixi for Management of Type 2 Diabetes in Japanese Clinical Practice: SPARTA Japan, a Retrospective Observational Study.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 1, p. 219, doi. 10.1007/s13300-022-01333-w
- By:
- Publication type:
- Article